Advertisement
Canada markets closed
  • S&P/TSX

    22,290.62
    +31.15 (+0.14%)
     
  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     
  • DOW

    38,884.26
    +31.99 (+0.08%)
     
  • CAD/USD

    0.7286
    -0.0035 (-0.48%)
     
  • CRUDE OIL

    78.37
    -0.11 (-0.14%)
     
  • Bitcoin CAD

    86,668.07
    -461.54 (-0.53%)
     
  • CMC Crypto 200

    1,308.29
    -56.83 (-4.16%)
     
  • GOLD FUTURES

    2,322.50
    -8.70 (-0.37%)
     
  • RUSSELL 2000

    2,064.65
    +3.97 (+0.19%)
     
  • 10-Yr Bond

    4.4630
    -0.0260 (-0.58%)
     
  • NASDAQ futures

    18,197.75
    +2.25 (+0.01%)
     
  • VOLATILITY

    13.23
    -0.26 (-1.93%)
     
  • FTSE

    8,313.67
    +100.18 (+1.22%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6770
    -0.0022 (-0.32%)
     

Stocks in play: Zenabis Global Inc.

Has successfully received EU-GMP approval for its Atholville facility and expects to commence commercial export to the European Union in the third quarter of 2020. In addition, the Company is announcing Health Canada approval of additional growing and processing areas at Zenabis Langley. Zenabis Global Inc. shares T.ZENA are trading up $0.005 at $0.18.

Read: